- Home
- AVNS vs VALN Comparison
AVNS vs VALN Comparison
Compare AVNS & VALN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVNS
- VALN
- Stock Information
- Founded
- AVNS 2014
- VALN 2012
- Country
- AVNS United States
- VALN France
- Employees
- AVNS N/A
- VALN N/A
- Industry
- AVNS Industrial Specialties
- VALN Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- AVNS Health Care
- VALN Health Care
- Exchange
- AVNS Nasdaq
- VALN Nasdaq
- Market Cap
- AVNS 591.9M
- VALN 542.5M
- IPO Year
- AVNS N/A
- VALN 2021
- Fundamental
- Price
- AVNS $11.93
- VALN $6.00
- Analyst Decision
- AVNS
- VALN Strong Buy
- Analyst Count
- AVNS 0
- VALN 3
- Target Price
- AVNS N/A
- VALN $15.33
- AVG Volume (30 Days)
- AVNS 420.8K
- VALN 14.6K
- Earning Date
- AVNS 07-30-2025
- VALN 08-12-2025
- Dividend Yield
- AVNS N/A
- VALN N/A
- EPS Growth
- AVNS N/A
- VALN N/A
- EPS
- AVNS N/A
- VALN N/A
- Revenue
- AVNS $689,200,000.00
- VALN $201,099,222.00
- Revenue This Year
- AVNS N/A
- VALN $18.74
- Revenue Next Year
- AVNS $3.42
- VALN $29.26
- P/E Ratio
- AVNS N/A
- VALN N/A
- Revenue Growth
- AVNS 1.34
- VALN 21.64
- 52 Week Low
- AVNS $11.68
- VALN $3.62
- 52 Week High
- AVNS $25.36
- VALN $8.66
- Technical
- Relative Strength Index (RSI)
- AVNS 42.73
- VALN 52.41
- Support Level
- AVNS $11.68
- VALN $5.57
- Resistance Level
- AVNS $12.50
- VALN $6.19
- Average True Range (ATR)
- AVNS 0.35
- VALN 0.29
- MACD
- AVNS -0.00
- VALN 0.05
- Stochastic Oscillator
- AVNS 21.78
- VALN 65.60
About AVNS Avanos Medical Inc.
Avanos Medical Inc is a United States-based company that develops and sells medical devices and related services globally. Its operating and reportable segment provides medical device products to healthcare providers and patients. The company has now changed two franchises: has combined Chronic Care and Pain Management franchises into a single commercial organization focused on the Digestive Health and Pain Management and Recovery product categories that generate its revenue from its Chronic Care franchise and in North America.
About VALN Valneva SE
Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.